Cargando…
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome
The necessity to accurately predict recurrence and clinical outcome in early stage colorectal cancer (CRC) is critical to identify those patients who may benefit from adjuvant chemotherapy. Here, we developed and validated a gene‐based risk‐score algorithm for patient stratification and personalised...
Autores principales: | Robles, Javier, Pintado‐Berninches, Laura, Boukich, Issam, Escudero, Beatriz, de los Rios, Vivian, Bartolomé, Rubén A, Jaén, Marta, Martín‐Regalado, Ángela, Fernandez‐Aceñero, María Jesús, Imbaud, Juan Ignacio, Casal, José Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535096/ https://www.ncbi.nlm.nih.gov/pubmed/36134447 http://dx.doi.org/10.1002/cjp2.294 |
Ejemplares similares
-
CDH6‐activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers
por: Bartolomé, Rubén A., et al.
Publicado: (2021) -
Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2
por: Bartolomé, Rubén A., et al.
Publicado: (2023) -
Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies
por: Jaén, Marta, et al.
Publicado: (2021) -
Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells
por: Bartolomé, Rubén A., et al.
Publicado: (2020) -
An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer
por: Bartolomé, Rubén A., et al.
Publicado: (2018)